American Society of Consultant Pharmacists v. Concannon

214 F. Supp. 2d 23, 2002 U.S. Dist. LEXIS 15578, 2002 WL 1930007
CourtDistrict Court, D. Maine
DecidedAugust 19, 2002
Docket2:02-cv-00115
StatusPublished
Cited by15 cases

This text of 214 F. Supp. 2d 23 (American Society of Consultant Pharmacists v. Concannon) is published on Counsel Stack Legal Research, covering District Court, D. Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Society of Consultant Pharmacists v. Concannon, 214 F. Supp. 2d 23, 2002 U.S. Dist. LEXIS 15578, 2002 WL 1930007 (D. Me. 2002).

Opinion

FINDINGS OF FACT AND CONCLUSIONS OF LAW

SINGAL, District Judge.

An organization representing pharmacists sued the Maine Department of Human Services (DHS), alleging that DHS violated federal Medicaid law and state administrative procedure when it imposed an emergency rule reducing reimbursement rates for prescription drugs. Presently before the Court is Plaintiffs Motion for Preliminary Injunction (Docket # 13). Having held an evidentiary hearing August 6, 2002, the Court makes the following findings of fact and conclusions of law, and DENIES the Motion.

I. FINDINGS OF FACT

On July 1, 2002, Defendant DHS issued an “emergency rule” reducing the rate at which pharmacists participating in Maine’s Medicaid program (known as “Maine-Care”) were reimbursed for filling prescriptions for Medicaid-eligible customers. *25 Before DHS issued the rule, it paid pharmacists an amount equaling the “Average Wholesale Price” (AWP) (an industry-standard price) of drugs minus ten percent, plus a $3.35 “dispensing fee” for each prescription filled. The new rule augmented the discount on AWP to thirteen percent. Plaintiff American Society of Consultant Pharmacists (ASCP), a trade organization representing pharmacists in Maine, sued to enjoin the emergency rate reduction, arguing that its members had not received adequate notice or opportunity to comment on it, and that the rate was substantively infirm.

DHS implemented the rate change in response to Maine’s current fiscal crisis. In late April 2002, Maine budget and treasury officials concluded that the State’s income tax revenues for the 2001 tax year had fallen well short of anticipated levels, resulting in a projected budget deficit of roughly $170 million by the end of fiscal year 2003. Maine Governor Angus King responded by instructing state agencies to pare their FY 2003 budgets by two percent. DHS achieved this goal by proposing cuts in funding for a variety of health care services, including the AWP rate cut.

The Maine Bureau of Medical Services (BMS), the division of DHS responsible for administering MaineCare, was instrumental in formulating the AWP cut. It weighed a number of budget reduction measures before settling on the AWP rate cut, which it determined would do the least harm to Medicaid recipients’ access to and quality of Medicaid services. In coming to this conclusion, BMS took into account several studies that indicated that the old AWP rate was above the national average and could be reduced without significant detriment to the Maine pharmaceutical industry. It also consulted the Maine legislature.

ASCP member pharmacists received little warning of the cut. On Saturday, June 29, and Sunday, June 30, 2002, a notice appeared in newspapers serving the areas of Bangor, Maine, and Portland, Maine, advertising the implementation of the new AWP rate as of July 1, 2002. It also announced the rulemaking to implement the rule permanently, the notice and comment period for which commenced the same day.

Nearly every .pharmacist in Maine fills prescriptions for Medicaid recipients, who may be either “walk-in” customers, or residents of nursing facilities. Large, national chain pharmacies typically serve only the former. Smaller, independent pharmacies may serve only one type of customer, or both. Those that serve nursing home residents do so either at the request of a particular customer, or by contracting with a nursing home to be the default prescription-filler for all of its residents who do not have a preference for a specific pharmacist. Regardless of whether the pharmacists’ Medicaid customers are walk-ins or nursing home residents, DHS reimburses all Medicaid participating pharmacists at the same rate for their prescription-filling services.

ASCP filed its suit on' July 16, 2002, asserting a cause of action pursuant to 42 U.S.C. § 1983. The Court (Carter, J.) issued a temporary restraining order enjoining enforcement of the rate cut on July 29, 2002, and ASCP moved to convert the TRO to a preliminary injunction. The Court (Singal, J.) declined to extend the TRO when it expired on August 8, treating ASCP’s motion as one for preliminary injunction (Docket # 17). 1

*26 II. DISCUSSION

To be entitled to a preliminary injunction, Plaintiff must demonstrate that (1) it will suffer irreparable injury if the injunction is not granted; (2) such injury outweighs any harm that granting injunctive relief would inflict on the Defendant; (3) it has exhibited a likelihood of success on the merits; and (4) the public interest will not be adversely affected by the granting of the injunction. See Planned Parenthood League v. Bellotti, 641 F.2d 1006, 1009 (1st Cir.1981); Merrill Lynch v. Bennert, 980 F.Supp. 73, 74 (D.Me.1997). The third factor sets a threshold. See New Comm Wireless Servs. v. SprintCom, Inc., 287 F.3d 1, 9 (1st Cir.2002) (“The sine qua non of this four-part inquiry is likelihood of success on the merits: if the moving party cannot demonstrate that he is likely to succeed in his quest, the remaining factors become matters of idle curiosity”). Fundamental to success on the merits is existence of a cause of action. Plaintiff asserts a cause of action pursuant to 42 U.S.C. § 1983 for violation of two sections of 42 U.S.C. § 1396a. It is not obvious that any plaintiff would have a Section 1983 action to enforce these sections, and therefore the Court begins its analysis with that inquiry.

A. Existence of a Cause of Action

1. Overview of Medicaid Statute

In 1966, Congress enacted Title XIX of the Social Security Act establishing the federal Medicaid program, which aimed to provide health care to needy individuals. Title XIX is a so-called “funding statute,” by which Congress allocates federal funds to states in exchange for their participation in a federal program. See generally Harris v. McRae, 448 U.S. 297, 308, 100 S.Ct. 2671, 65 L.Ed.2d 784 (1980). States are not required to participate in Medicaid. However, if they wish to receive funding, they must formulate a plan that is consistent with Title XIX and submit it to the federal Department of Health and Human Services (DHHS) for approval. See 42 U.S.C. § 1302; 42 C.F.R. § 430.10 (2001).

The requirements that a state Medicaid plan must meet to obtain DHHS approval are listed at 42 U.S.C. § 1396a.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

NH Hospital Assoc., et al. v Burwell, et al.
2017 DNH 040 (D. New Hampshire, 2017)
Asante v. California Department of Health Care Services
155 F. Supp. 3d 1008 (N.D. California, 2015)
Holmes v. Constantino
999 F. Supp. 2d 345 (D. Rhode Island, 2014)
Arizona Hospital & Healthcare Ass'n v. Betlach
862 F. Supp. 2d 978 (D. Arizona, 2012)
Dartmouth-Hitchcock Clinic v. Toumpas
856 F. Supp. 2d 315 (D. New Hampshire, 2012)
Mission Hospital Regional Medical Center v. Shewry
168 Cal. App. 4th 460 (California Court of Appeal, 2008)
Clark v. Richman
339 F. Supp. 2d 631 (M.D. Pennsylvania, 2004)
In Re NYAHSA Litigation
318 F. Supp. 2d 30 (N.D. New York, 2004)
Long Term Care Pharmacy Alliance v. Ferguson
362 F.3d 50 (First Circuit, 2004)
Long Term Care Pharmacy Alliance v. Ferguson
260 F. Supp. 2d 282 (D. Massachusetts, 2003)
Rencor Controls, Inc. v. Stinson
230 F. Supp. 2d 99 (D. Maine, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
214 F. Supp. 2d 23, 2002 U.S. Dist. LEXIS 15578, 2002 WL 1930007, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-society-of-consultant-pharmacists-v-concannon-med-2002.